{"id":58769,"date":"2024-01-24T19:03:28","date_gmt":"2024-01-24T18:03:28","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/"},"modified":"2024-01-24T19:03:28","modified_gmt":"2024-01-24T18:03:28","slug":"why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/","title":{"rendered":"Why Investors and Media are Calling Biotech Showcase\u2122 \u201cThe Place to Be to Start the Year\u201d"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<b><i>Biotech Showcase\u2122 2024 Concludes with 3,400 attendees, 350 Presenting Companies, 1,250+ Investors and 100+ Members of the Media<\/i><\/b><\/p>\n<p>SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/BiotechShowcase?src=hash\" target=\"_blank\" rel=\"noopener\">#BiotechShowcase<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdemy-colton.com%2F&amp;esheet=53887393&amp;newsitemid=20240124431902&amp;lan=en-US&amp;anchor=Demy-Colton&amp;index=1&amp;md5=7acc3958384a5ee7a44af821b816997a\" rel=\"nofollow noopener\" shape=\"rect\">Demy-Colton<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ebdgroup.com%2F&amp;esheet=53887393&amp;newsitemid=20240124431902&amp;lan=en-US&amp;anchor=EBD+Group&amp;index=2&amp;md5=fe182479ed1fb6fd734475fddda28118\" rel=\"nofollow noopener\" shape=\"rect\">EBD Group<\/a>\u2019s <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finformaconnect.com%2Fbiotech-showcase%2F&amp;esheet=53887393&amp;newsitemid=20240124431902&amp;lan=en-US&amp;anchor=Biotech+Showcase&amp;index=3&amp;md5=b3900504f9a7046b1f9144bb489c1dec\" rel=\"nofollow noopener\" shape=\"rect\">Biotech Showcase<\/a>\u2122, the premier investor conference for private and micro to mid-cap biotechnology companies, concluded its 16th year, bringing together over 3,400 attendees \u2013 including a record-breaking 1,285 investors and 110 members of the media.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20240124431902\/en\/2008305\/5\/BiotechShowcase.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240124431902\/en\/2008305\/21\/BiotechShowcase.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240124431902\/en\/2008305\/5\/BiotechShowcase.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240124431902\/en\/2008305\/22\/BiotechShowcase.jpg\"><\/a><\/p>\n<p>\nMary Schaheen, President of Prevail Partners, said, \u201cAs an active investor in clinical-stage biotech (both public and private companies), this is a must-attend conference. Biotech Showcase\u2122 is true to its name \u2013 great companies are highlighted.\u201d<\/p>\n<p>\nTina Elder, Global Managing Director, EBD Group US, said, \u201cBiotech Showcase\u2122 has once again shown itself to be the premiere destination for innovators and partners to access a powerful network of industry decision-makers, media and top investors. Many thanks to all our investors, speakers, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finformaconnect.com%2Fbiotech-showcase%2Fsponsor-showcase%2F&amp;esheet=53887393&amp;newsitemid=20240124431902&amp;lan=en-US&amp;anchor=sponsors&amp;index=4&amp;md5=af086b51fa28c35d577ee7c9c258fe7e\" rel=\"nofollow noopener\" shape=\"rect\">sponsors<\/a> and other attendees for enabling these important conversations that help drive the industry\u2019s funding, collaboration and therapeutic breakthroughs.\u201d<\/p>\n<p>\nThis year\u2019s Biotech Showcase\u2122, which also encompasses Seed Showcase and DigiMed Showcase, explored the groundbreaking innovations set to define 2024. Discussions covered a broad range of topics, including the transition of focus from rare to chronic illnesses, strategies to combat neurodegenerative diseases, and insights into navigating the biotech funding landscape. 120 <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finformaconnect.com%2Fbiotech-showcase%2Fspeakers%2F&amp;esheet=53887393&amp;newsitemid=20240124431902&amp;lan=en-US&amp;anchor=speakers&amp;index=5&amp;md5=f1e864f52291132dea863a5a08997c55\" rel=\"nofollow noopener\" shape=\"rect\">speakers<\/a> shared their insights and perspectives on various industry fronts, including:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nMaha Katabi, General Partner, Sofinnova Investments<\/li>\n<li>\nBrent Vaughan, CEO, Cognito Therapeutics<\/li>\n<li>\nSamarth Kulkarni, CEO, CRISPR<\/li>\n<li>\nPaul Stoffels, CEO &amp; Chairman, Galapagos<\/li>\n<li>\nDaniel Kraft, Founder &amp; Chair, NextMed Health<\/li>\n<li>\nSeema Kumar, CEO, Cure<\/li>\n<li>\nTed Love, Chairman, Biotechnology Innovation Organization<\/li>\n<li>\nAshley Zehnder, Co-Founder &amp; CEO, Fauna Bio<\/li>\n<li>\nPaul Bresge, CEO, Ray Therapeutics<\/li>\n<li>\nJohn McDonald, Corporate Vice President, Global Head of Business Development and M&amp;A, Novo Nordisk<\/li>\n<li>\nAnd members of the media, including Adam Bluestein (Fast Company), Allison DeAngelis (STAT News), Kyle LaHucik (Endpoints News), Ron Leuty (San Francisco Business Times), Alex Philippidis (GEN) and David Ewing Duncan.<\/li>\n<\/ul>\n<p>\nSara Jane Demy, Founder and CEO of Demy-Colton, said, \u201cThis has been another successful year for Biotech Showcase\u2122, with an unmistakable sense of excitement and buzz about the industry\u2019s prospects for the year ahead. It affirms that this is the place to be to network, break news, find out what\u2019s happening, get a read on the mood around key issues, and meet with companies, investors and media.\u201d<\/p>\n<p>\nBiotech Showcase\u2122 also featured 350 companies, including public and private innovators, who provided company presentations, while attendees networked via 6,500 partnering meetings, both in-person and virtual. Sessions from Biotech Showcase\u2122, including company presentations, audio recordings of all panels and other content, are available for registered attendees on the partneringONE\u00ae platform. Those interested in accessing program content can log in with their registration information.<\/p>\n<p>\nFor more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.biotechshowcase.com&amp;esheet=53887393&amp;newsitemid=20240124431902&amp;lan=en-US&amp;anchor=www.biotechshowcase.com&amp;index=6&amp;md5=579bfc241a7f79dd0e19b92994af0c1d\" rel=\"nofollow noopener\" shape=\"rect\">www.biotechshowcase.com<\/a> or follow us on Twitter @DemyColton and @EBDGroup.<\/p>\n<p>\n<b>About Demy-Colton<\/b><\/p>\n<p>\nDemy-Colton is a leading life sciences and digital health events organization, at the forefront of building networks between innovative life sciences companies and industry stakeholders. Its unique events facilitate networking on a global scale, including Biotech Showcase\u2122, BioFuture\u2122, Biotech CEO Summit Europe\u2122, Biotech CEO Summit\u2122 in La Jolla, and Demy-Colton Virtual Salons. These events build networking communities that transcend geographical boundaries and establish ongoing, high-value relationships among the industry\u2019s top decision-makers, investors and thought leaders, where investment, learning, and thoughtful conversations thrive. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.demy-colton.com%2F&amp;esheet=53887393&amp;newsitemid=20240124431902&amp;lan=en-US&amp;anchor=www.demy-colton.com&amp;index=7&amp;md5=7f745949ff795dbbf7ca146b770ca8a7\" rel=\"nofollow noopener\" shape=\"rect\">www.demy-colton.com<\/a>.<\/p>\n<p>\n<b>About EBD Group<\/b><\/p>\n<p>\nEBD Group\u2019s overriding mission is to help collaborations get started across the life sciences value chain. Our range of partnering conferences has grown to become the largest and most productive conference platform in the industry. Each one of our landmark events held in key life sciences markets around the world is powered by our state-of-the-art partnering software, partneringONE\u00ae, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings. Today, our events (BIO-Europe\u00ae, BIO-Europe Spring\u00ae, BioPharm America\u2122, Biotech Showcase\u2122, ChinaBio\u00ae Partnering Forum, Rare Disease Innovation and Partnering Summit, and BioEquity Europe) annually attract more than 15,000 senior life sciences executives who engage in over 50,000 one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry. For more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ebdgroup.com%2F&amp;esheet=53887393&amp;newsitemid=20240124431902&amp;lan=en-US&amp;anchor=www.ebdgroup.com&amp;index=8&amp;md5=a28e6d564f21afbd6401d9b2941a9c89\" rel=\"nofollow noopener\" shape=\"rect\">www.ebdgroup.com<\/a>.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nKatie Morris<br \/>\n<br \/>ENTENTE Network of Companies<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#105;&#x6c;&#x74;o:&#107;&#97;&#x74;&#x68;ry&#110;&#109;&#x6f;&#x72;ri&#115;&#x40;&#x65;&#x6e;t&#101;&#110;&#x74;&#x65;&#x69;n&#99;&#46;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6b;&#x61;&#x74;&#x68;&#114;&#121;&#110;mo&#x72;&#x72;&#x69;&#x73;&#x40;&#101;&#110;&#116;en&#x74;&#x65;&#x69;&#x6e;&#x63;&#46;&#99;&#111;m<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Biotech Showcase\u2122 2024 Concludes with 3,400 attendees, 350 Presenting Companies, 1,250+ Investors and 100+ Members of the Media SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;#BiotechShowcase&#8212;Demy-Colton and EBD Group\u2019s Biotech Showcase\u2122, the premier investor conference for private and micro to mid-cap biotechnology companies, concluded its 16th year, bringing together over 3,400 attendees \u2013 including a record-breaking 1,285 investors and 110 &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58769","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Why Investors and Media are Calling Biotech Showcase\u2122 \u201cThe Place to Be to Start the Year\u201d - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Why Investors and Media are Calling Biotech Showcase\u2122 \u201cThe Place to Be to Start the Year\u201d - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Biotech Showcase\u2122 2024 Concludes with 3,400 attendees, 350 Presenting Companies, 1,250+ Investors and 100+ Members of the Media SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;#BiotechShowcase&#8212;Demy-Colton and EBD Group\u2019s Biotech Showcase\u2122, the premier investor conference for private and micro to mid-cap biotechnology companies, concluded its 16th year, bringing together over 3,400 attendees \u2013 including a record-breaking 1,285 investors and 110 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-24T18:03:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240124431902\/en\/2008305\/21\/BiotechShowcase.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Why Investors and Media are Calling Biotech Showcase\u2122 \u201cThe Place to Be to Start the Year\u201d\",\"datePublished\":\"2024-01-24T18:03:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\\\/\"},\"wordCount\":711,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240124431902\\\/en\\\/2008305\\\/21\\\/BiotechShowcase.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\\\/\",\"name\":\"Why Investors and Media are Calling Biotech Showcase\u2122 \u201cThe Place to Be to Start the Year\u201d - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240124431902\\\/en\\\/2008305\\\/21\\\/BiotechShowcase.jpg\",\"datePublished\":\"2024-01-24T18:03:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240124431902\\\/en\\\/2008305\\\/21\\\/BiotechShowcase.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240124431902\\\/en\\\/2008305\\\/21\\\/BiotechShowcase.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Why Investors and Media are Calling Biotech Showcase\u2122 \u201cThe Place to Be to Start the Year\u201d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Why Investors and Media are Calling Biotech Showcase\u2122 \u201cThe Place to Be to Start the Year\u201d - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/","og_locale":"en_US","og_type":"article","og_title":"Why Investors and Media are Calling Biotech Showcase\u2122 \u201cThe Place to Be to Start the Year\u201d - Pharma Trend","og_description":"Biotech Showcase\u2122 2024 Concludes with 3,400 attendees, 350 Presenting Companies, 1,250+ Investors and 100+ Members of the Media SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;#BiotechShowcase&#8212;Demy-Colton and EBD Group\u2019s Biotech Showcase\u2122, the premier investor conference for private and micro to mid-cap biotechnology companies, concluded its 16th year, bringing together over 3,400 attendees \u2013 including a record-breaking 1,285 investors and 110 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/","og_site_name":"Pharma Trend","article_published_time":"2024-01-24T18:03:28+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240124431902\/en\/2008305\/21\/BiotechShowcase.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Why Investors and Media are Calling Biotech Showcase\u2122 \u201cThe Place to Be to Start the Year\u201d","datePublished":"2024-01-24T18:03:28+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/"},"wordCount":711,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240124431902\/en\/2008305\/21\/BiotechShowcase.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/","url":"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/","name":"Why Investors and Media are Calling Biotech Showcase\u2122 \u201cThe Place to Be to Start the Year\u201d - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240124431902\/en\/2008305\/21\/BiotechShowcase.jpg","datePublished":"2024-01-24T18:03:28+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240124431902\/en\/2008305\/21\/BiotechShowcase.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240124431902\/en\/2008305\/21\/BiotechShowcase.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/why-investors-and-media-are-calling-biotech-showcase-the-place-to-be-to-start-the-year\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Why Investors and Media are Calling Biotech Showcase\u2122 \u201cThe Place to Be to Start the Year\u201d"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58769","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58769"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58769\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58769"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58769"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58769"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}